Atlas Startup, Rodin Therapeutics, Hopes to Rewire Neurons to Improve Memory  
8/14/2013 7:07:53 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Epigenetics isn’t new. But so far, the growing scientific understanding of gene regulation has largely been used to make cancer drugs. What if you could use the same concept to reprogram neurons to combat neurological disorders? This is the plan that Atlas Venture has shaped for its new startup, Rodin Therapeutics.

Help employers find you! Check out all the jobs and post your resume.